Late-breaking data show reliable performance of small-diameter defibrillation lead, the Medtronic OmniaSecure™
- Written by PR Newswire
![]() |
Global LEADR clinical trial meets safety and effectiveness objectives; results presented at Heart Rhythm 2024 and simultaneously published in Heart Rhythm
DUBLIN and BOSTON, May 17, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announced that its investigational OmniaSecure™ defibrillation lead...















